Skip to search formSkip to main contentSkip to account menu

SB 217242

Known as: SB-217242 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

enrasentan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Attenuated endothelin‐1 mRNA expression with endothelin‐1 receptor blockade during hypoxaemia and reoxygenation in newborn piglets
We investigated the cause of decreased plasma endothelin‐1 (ET‐1) during hypoxaemia and reoxygenation in newborn piglets… 
2000
2000
Attenuated endothelin- mRNA expression with endothelin- receptor blockade during hypoxaemia and reoxygenation in newborn piglets.
UNLABELLED We investigated the cause of decreased plasma endothelin-1 (ET-1) during hypoxaemia and reoxygenation in newborn… 
1999
1999
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
The effects of SB 217242, a non-peptide endothelin (ET) receptor antagonist, were investigated against hypoxia-induced… 
1999
1999
Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits.
Embryo-fetal development studies with toxicokinetic evaluations were conducted in rats and rabbits after oral or intravenous… 
1999
1999
Pulmonary Hemodynamics in Newborn Piglets during Hypoxemia and Reoxygenation: Blocking of the Endothelin-1 Receptors
The effects of blocking endothelin (ET) receptors in pulmonary circulation during hypoxemia and reoxygenation were studied in… 
1999
1999
Trigeminal nerve ganglion stimulation‐induced neurovascular reflexes in the anaesthetized cat: Role of endothelinB receptors in carotid vasodilatation
The effects of intravenous administration of endothelin (ET) receptor antagonists SB‐209670 (0.001–10.0 mg kg−1), SB‐217242, SB… 
1998
1998
Chronic hypoxia-induced cardiopulmonary changes in three rat strains: inhibition by the endothelin receptor antagonist SB 217242.
The cardiopulmonary profile of three different rat strains was compared after exposure to hypoxia (9% O2) for 0, 7, or 14 days… 
1998
1998
Application of serial in vivo magnetic resonance imaging to evaluate the efficacy of endothelin receptor antagonist SB 217242 in the rat carotid artery model of neointima formation.
BACKGROUND Alleviating vascular restenosis after percutaneous transluminal angioplasty remains a formidable challenge. Although… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)